 | • レポートコード：D005-10163 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、変形性関節症鎮痛剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。変形性関節症鎮痛剤の種類別市場規模（経口、注射、外用）、用途別市場規模（医療、パーソナルケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Horizon Pharma、Bayer、Johnson and Johnson、Sanofi、GlaxoSmithKline、Mylan、Novartis、Eli Lilly、Abbott、Tide Pharmaceutical、Abiogen Pharma、Daiichi Sankyo、Iroko Pharmaceuticals、Astellas Pharma、TEVA、Hengrui Pharmaceutical、Almatica Pharma ・地域別グローバル市場分析 2015年-2020年 ・変形性関節症鎮痛剤の北米市場（アメリカ、カナダ、メキシコ） ・変形性関節症鎮痛剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・変形性関節症鎮痛剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・変形性関節症鎮痛剤の南米市場（ブラジル、アルゼンチン） ・変形性関節症鎮痛剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、注射、外用 ・用途別分析：医療、パーソナルケア ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Medicine for Osteoarthritis Pain market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.4% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Medicine for Osteoarthritis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Medicine for Osteoarthritis Pain market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Medicine for Osteoarthritis Pain market has been segmented into
Oral
Injection
External
By Application, Medicine for Osteoarthritis Pain has been segmented into:
Medical Care
Personal Care
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Medicine for Osteoarthritis Pain market presented in the report. This section sheds light on the sales growth of different regional and country-level Medicine for Osteoarthritis Pain markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Medicine for Osteoarthritis Pain market.
The report offers in-depth assessment of the growth and other aspects of the Medicine for Osteoarthritis Pain market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Medicine for Osteoarthritis Pain Market Share Analysis
Medicine for Osteoarthritis Pain competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Medicine for Osteoarthritis Pain sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Medicine for Osteoarthritis Pain sales, revenue and market share for each player covered in this report.
The major players covered in Medicine for Osteoarthritis Pain are:
Pfizer
Horizon Pharma
Bayer
Johnson and Johnson
Sanofi
GlaxoSmithKline
Mylan
Novartis
Eli Lilly
Abbott
Tide Pharmaceutical
Abiogen Pharma
Daiichi Sankyo
Iroko Pharmaceuticals
Astellas Pharma
TEVA
Hengrui Pharmaceutical
Almatica Pharma
Among other players domestic and global, Medicine for Osteoarthritis Pain market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medicine for Osteoarthritis Pain product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Medicine for Osteoarthritis Pain, with price, sales, revenue and global market share of Medicine for Osteoarthritis Pain in 2018 and 2019.
Chapter 3, the Medicine for Osteoarthritis Pain competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medicine for Osteoarthritis Pain breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Medicine for Osteoarthritis Pain market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Medicine for Osteoarthritis Pain sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Medicine for Osteoarthritis Pain Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Medicine for Osteoarthritis Pain Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market Analysis by Application
1.3.1 Overview: Global Medicine for Osteoarthritis Pain Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Overview of Global Medicine for Osteoarthritis Pain Market
1.4.1 Global Medicine for Osteoarthritis Pain Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Horizon Pharma
2.2.1 Horizon Pharma Details
2.2.2 Horizon Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Horizon Pharma SWOT Analysis
2.2.4 Horizon Pharma Product and Services
2.2.5 Horizon Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson and Johnson
2.4.1 Johnson and Johnson Details
2.4.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson and Johnson SWOT Analysis
2.4.4 Johnson and Johnson Product and Services
2.4.5 Johnson and Johnson Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan SWOT Analysis
2.7.4 Mylan Product and Services
2.7.5 Mylan Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Eli Lilly SWOT Analysis
2.9.4 Eli Lilly Product and Services
2.9.5 Eli Lilly Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Abbott SWOT Analysis
2.10.4 Abbott Product and Services
2.10.5 Abbott Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Tide Pharmaceutical
2.11.1 Tide Pharmaceutical Details
2.11.2 Tide Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Tide Pharmaceutical SWOT Analysis
2.11.4 Tide Pharmaceutical Product and Services
2.11.5 Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Abiogen Pharma
2.12.1 Abiogen Pharma Details
2.12.2 Abiogen Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Abiogen Pharma SWOT Analysis
2.12.4 Abiogen Pharma Product and Services
2.12.5 Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Daiichi Sankyo
2.13.1 Daiichi Sankyo Details
2.13.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Daiichi Sankyo SWOT Analysis
2.13.4 Daiichi Sankyo Product and Services
2.13.5 Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Iroko Pharmaceuticals
2.14.1 Iroko Pharmaceuticals Details
2.14.2 Iroko Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Iroko Pharmaceuticals SWOT Analysis
2.14.4 Iroko Pharmaceuticals Product and Services
2.14.5 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Astellas Pharma
2.15.1 Astellas Pharma Details
2.15.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Astellas Pharma SWOT Analysis
2.15.4 Astellas Pharma Product and Services
2.15.5 Astellas Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 TEVA
2.16.1 TEVA Details
2.16.2 TEVA Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 TEVA SWOT Analysis
2.16.4 TEVA Product and Services
2.16.5 TEVA Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hengrui Pharmaceutical
2.17.1 Hengrui Pharmaceutical Details
2.17.2 Hengrui Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Hengrui Pharmaceutical SWOT Analysis
2.17.4 Hengrui Pharmaceutical Product and Services
2.17.5 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Almatica Pharma
2.18.1 Almatica Pharma Details
2.18.2 Almatica Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Almatica Pharma SWOT Analysis
2.18.4 Almatica Pharma Product and Services
2.18.5 Almatica Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Medicine for Osteoarthritis Pain Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Medicine for Osteoarthritis Pain Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Medicine for Osteoarthritis Pain Manufacturer Market Share in 2019
3.3.2 Top 6 Medicine for Osteoarthritis Pain Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Medicine for Osteoarthritis Pain Sales, Revenue and Market Share by Regions
4.1.1 Global Medicine for Osteoarthritis Pain Sales and Market Share by Regions (2015-2020)
4.1.2 Global Medicine for Osteoarthritis Pain Revenue and Market Share by Regions (2015-2020)
4.2 North America Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
4.3 Europe Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
4.5 South America Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Medicine for Osteoarthritis Pain Sales, Revenue and Market Share by Country
5.1.1 North America Medicine for Osteoarthritis Pain Sales and Market Share by Country (2015-2020)
5.1.2 North America Medicine for Osteoarthritis Pain Revenue and Market Share by Country (2015-2020)
5.2 United States Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
5.3 Canada Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
5.4 Mexico Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Medicine for Osteoarthritis Pain Sales, Revenue and Market Share by Country
6.1.1 Europe Medicine for Osteoarthritis Pain Sales and Market Share by Country (2015-2020)
6.1.2 Europe Medicine for Osteoarthritis Pain Revenue and Market Share by Country (2015-2020)
6.2 Germany Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
6.3 UK Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
6.4 France Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
6.5 Russia Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
6.6 Italy Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Medicine for Osteoarthritis Pain Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Medicine for Osteoarthritis Pain Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Medicine for Osteoarthritis Pain Revenue and Market Share by Regions (2015-2020)
7.2 China Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7.3 Japan Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7.4 Korea Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7.5 India Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
7.7 Australia Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Medicine for Osteoarthritis Pain Sales, Revenue and Market Share by Country
8.1.1 South America Medicine for Osteoarthritis Pain Sales and Market Share by Country (2015-2020)
8.1.2 South America Medicine for Osteoarthritis Pain Revenue and Market Share by Country (2015-2020)
8.2 Brazil Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
8.3 Argentina Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Medicine for Osteoarthritis Pain Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Medicine for Osteoarthritis Pain Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Medicine for Osteoarthritis Pain Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
9.3 Turkey Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
9.4 Egypt Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
9.5 South Africa Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Medicine for Osteoarthritis Pain Sales and Market Share by Type (2015-2020)
10.2 Global Medicine for Osteoarthritis Pain Revenue and Market Share by Type (2015-2020)
10.3 Global Medicine for Osteoarthritis Pain Price by Type (2015-2020)
11 Global Medicine for Osteoarthritis Pain Market Segment by Application
11.1 Global Medicine for Osteoarthritis Pain Sales Market Share by Application (2015-2020)
11.2 Global Medicine for Osteoarthritis Pain Revenue Market Share by Application (2015-2020)
11.3 Global Medicine for Osteoarthritis Pain Price by Application (2015-2020)
12 Market Forecast
12.1 Global Medicine for Osteoarthritis Pain Sales, Revenue and Growth Rate (2021-2025)
12.2 Medicine for Osteoarthritis Pain Market Forecast by Regions (2021-2025)
12.2.1 North America Medicine for Osteoarthritis Pain Market Forecast (2021-2025)
12.2.2 Europe Medicine for Osteoarthritis Pain Market Forecast (2021-2025)
12.2.3 Asia-Pacific Medicine for Osteoarthritis Pain Market Forecast (2021-2025)
12.2.4 South America Medicine for Osteoarthritis Pain Market Forecast (2021-2025)
12.2.5 Middle East & Africa Medicine for Osteoarthritis Pain Market Forecast (2021-2025)
12.3 Medicine for Osteoarthritis Pain Market Forecast by Type (2021-2025)
12.3.1 Global Medicine for Osteoarthritis Pain Sales Forecast by Type (2021-2025)
12.3.2 Global Medicine for Osteoarthritis Pain Market Share Forecast by Type (2021-2025)
12.4 Medicine for Osteoarthritis Pain Market Forecast by Application (2021-2025)
12.4.1 Global Medicine for Osteoarthritis Pain Sales Forecast by Application (2021-2025)
12.4.2 Global Medicine for Osteoarthritis Pain Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Medicine for Osteoarthritis Pain Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Medicine for Osteoarthritis Pain by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Medicine for Osteoarthritis Pain Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Medicine for Osteoarthritis Pain Major Business
Table 9. Pfizer Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer Medicine for Osteoarthritis Pain Product and Services
Table 12. Pfizer Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Horizon Pharma Medicine for Osteoarthritis Pain Major Business
Table 15. Horizon Pharma Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 16. Horizon Pharma SWOT Analysis
Table 17. Horizon Pharma Medicine for Osteoarthritis Pain Product and Services
Table 18. Horizon Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Medicine for Osteoarthritis Pain Major Business
Table 21. Bayer Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 22. Bayer SWOT Analysis
Table 23. Bayer Medicine for Osteoarthritis Pain Product and Services
Table 24. Bayer Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson and Johnson Medicine for Osteoarthritis Pain Major Business
Table 27. Johnson and Johnson Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 28. Johnson and Johnson SWOT Analysis
Table 29. Johnson and Johnson Medicine for Osteoarthritis Pain Product and Services
Table 30. Johnson and Johnson Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Medicine for Osteoarthritis Pain Major Business
Table 33. Sanofi Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi SWOT Analysis
Table 35. Sanofi Medicine for Osteoarthritis Pain Product and Services
Table 36. Sanofi Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 38. GlaxoSmithKline Medicine for Osteoarthritis Pain Major Business
Table 39. GlaxoSmithKline Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 40. GlaxoSmithKline SWOT Analysis
Table 41. GlaxoSmithKline Medicine for Osteoarthritis Pain Product and Services
Table 42. GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Medicine for Osteoarthritis Pain Major Business
Table 45. Mylan Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 46. Mylan SWOT Analysis
Table 47. Mylan Medicine for Osteoarthritis Pain Product and Services
Table 48. Mylan Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Novartis Basic Information, Manufacturing Base and Competitors
Table 50. Novartis Medicine for Osteoarthritis Pain Major Business
Table 51. Novartis Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 52. Novartis SWOT Analysis
Table 53. Novartis Medicine for Osteoarthritis Pain Product and Services
Table 54. Novartis Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 56. Eli Lilly Medicine for Osteoarthritis Pain Major Business
Table 57. Eli Lilly Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 58. Eli Lilly SWOT Analysis
Table 59. Eli Lilly Medicine for Osteoarthritis Pain Product and Services
Table 60. Eli Lilly Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Abbott Basic Information, Manufacturing Base and Competitors
Table 62. Abbott Medicine for Osteoarthritis Pain Major Business
Table 63. Abbott Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 64. Abbott SWOT Analysis
Table 65. Abbott Medicine for Osteoarthritis Pain Product and Services
Table 66. Abbott Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Tide Pharmaceutical Medicine for Osteoarthritis Pain Major Business
Table 69. Tide Pharmaceutical Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 70. Tide Pharmaceutical SWOT Analysis
Table 71. Tide Pharmaceutical Medicine for Osteoarthritis Pain Product and Services
Table 72. Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Abiogen Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Abiogen Pharma Medicine for Osteoarthritis Pain Major Business
Table 75. Abiogen Pharma Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 76. Abiogen Pharma SWOT Analysis
Table 77. Abiogen Pharma Medicine for Osteoarthritis Pain Product and Services
Table 78. Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 80. Daiichi Sankyo Medicine for Osteoarthritis Pain Major Business
Table 81. Daiichi Sankyo Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 82. Daiichi Sankyo SWOT Analysis
Table 83. Daiichi Sankyo Medicine for Osteoarthritis Pain Product and Services
Table 84. Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Major Business
Table 87. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 88. Iroko Pharmaceuticals SWOT Analysis
Table 89. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product and Services
Table 90. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Astellas Pharma Medicine for Osteoarthritis Pain Major Business
Table 93. Astellas Pharma Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 94. Astellas Pharma SWOT Analysis
Table 95. Astellas Pharma Medicine for Osteoarthritis Pain Product and Services
Table 96. Astellas Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. TEVA Basic Information, Manufacturing Base and Competitors
Table 98. TEVA Medicine for Osteoarthritis Pain Major Business
Table 99. TEVA Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 100. TEVA SWOT Analysis
Table 101. TEVA Medicine for Osteoarthritis Pain Product and Services
Table 102. TEVA Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Major Business
Table 105. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 106. Hengrui Pharmaceutical SWOT Analysis
Table 107. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product and Services
Table 108. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Almatica Pharma Medicine for Osteoarthritis Pain Type and Application
Table 110. Almatica Pharma Medicine for Osteoarthritis Pain Major Business
Table 111. Almatica Pharma Medicine for Osteoarthritis Pain Total Revenue (USD Million) (2017-2018)
Table 112. Almatica Pharma SWOT Analysis
Table 113. Almatica Pharma Medicine for Osteoarthritis Pain Product and Services
Table 114. Almatica Pharma Medicine for Osteoarthritis Pain Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Global Medicine for Osteoarthritis Pain Sales by Manufacturer (2018-2019) (K Units)
Table 116. Global Medicine for Osteoarthritis Pain Revenue by Manufacturer (2018-2019) (USD Million)
Table 117. Global Medicine for Osteoarthritis Pain Sales by Regions (2015-2020) (K Units)
Table 118. Global Medicine for Osteoarthritis Pain Sales Market Share by Regions (2015-2020)
Table 119. Global Medicine for Osteoarthritis Pain Revenue by Regions (2015-2020) (USD Million)
Table 120. North America Medicine for Osteoarthritis Pain Sales by Countries (2015-2020) (K Units)
Table 121. North America Medicine for Osteoarthritis Pain Sales Market Share by Countries (2015-2020)
Table 122. North America Medicine for Osteoarthritis Pain Revenue by Countries (2015-2020) (USD Million)
Table 123. North America Medicine for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Table 124. Europe Medicine for Osteoarthritis Pain Sales by Countries (2015-2020) (K Units)
Table 125. Europe Medicine for Osteoarthritis Pain Sales Market Share by Countries (2015-2020)
Table 126. Europe Medicine for Osteoarthritis Pain Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Regions (2015-2020) (K Units)
Table 128. Asia-Pacific Medicine for Osteoarthritis Pain Sales Market Share by Regions (2015-2020)
Table 129. Asia-Pacific Medicine for Osteoarthritis Pain Revenue by Regions (2015-2020) (USD Million)
Table 130. South America Medicine for Osteoarthritis Pain Sales by Countries (2015-2020) (K Units)
Table 131. South America Medicine for Osteoarthritis Pain Sales Market Share by Countries (2015-2020)
Table 132. South America Medicine for Osteoarthritis Pain Revenue by Countries (2015-2020) (USD Million)
Table 133. South America Medicine for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Table 134. Middle East & Africa Medicine for Osteoarthritis Pain Sales by Countries (2015-2020) (K Units)
Table 135. Middle East & Africa Medicine for Osteoarthritis Pain Sales Market Share by Countries (2015-2020)
Table 136. Middle East & Africa Medicine for Osteoarthritis Pain Revenue by Countries (2015-2020) (USD Million)
Table 137. Middle East & Africa Medicine for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Table 138. Global Medicine for Osteoarthritis Pain Sales by Type (2015-2020) (K Units)
Table 139. Global Medicine for Osteoarthritis Pain Sales Share by Type (2015-2020)
Table 140. Global Medicine for Osteoarthritis Pain Revenue by Type (2015-2020) (USD Million)
Table 141. Global Medicine for Osteoarthritis Pain Revenue Share by Type (2015-2020)
Table 142. Global Medicine for Osteoarthritis Pain Sales by Application (2015-2020) (K Units)
Table 143. Global Medicine for Osteoarthritis Pain Sales Share by Application (2015-2020)
Table 144. Global Medicine for Osteoarthritis Pain Sales Forecast by Regions (2021-2025) (K Units)
Table 145. Global Medicine for Osteoarthritis Pain Market Share Forecast by Regions (2021-2025)
Table 146. Global Medicine for Osteoarthritis Pain Sales Forecast by Type (2021-2025) (K Units)
Table 147. Global Medicine for Osteoarthritis Pain Market Share Forecast by Type (2021-2025)
Table 148. Global Medicine for Osteoarthritis Pain Sales Forecast by Application (2021-2025)
Table 149. Global Medicine for Osteoarthritis Pain Market Share Forecast by Application (2021-2025)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Medicine for Osteoarthritis Pain Picture
Figure 2. Global Sales Market Share of Medicine for Osteoarthritis Pain by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. External Picture
Figure 6. Medicine for Osteoarthritis Pain Sales Market Share by Application in 2018
Figure 7. Medical Care Picture
Figure 8. Personal Care Picture
Figure 9. Global Medicine for Osteoarthritis Pain Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Medicine for Osteoarthritis Pain Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Medicine for Osteoarthritis Pain Sales Market Share by Manufacturer in 2019
Figure 30. Global Medicine for Osteoarthritis Pain Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Medicine for Osteoarthritis Pain Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Medicine for Osteoarthritis Pain Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Medicine for Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Medicine for Osteoarthritis Pain Revenue Market Share by Regions (2015-2020)
Figure 37. Global Medicine for Osteoarthritis Pain Revenue Market Share by Regions in 2018
Figure 38. North America Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
Figure 39. Europe Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
Figure 41. South America Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020)
Figure 43. North America Medicine for Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Medicine for Osteoarthritis Pain Sales Market Share by Countries (2015-2020)
Figure 45. North America Medicine for Osteoarthritis Pain Sales Market Share by Countries in 2018
Figure 46. North America Medicine for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Medicine for Osteoarthritis Pain Revenue Market Share by Countries in 2018
Figure 48. United States Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Medicine for Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Medicine for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Medicine for Osteoarthritis Pain Revenue Market Share by Countries in 2019
Figure 54. Germany Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Medicine for Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Medicine for Osteoarthritis Pain Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Medicine for Osteoarthritis Pain Revenue Market Share by Regions 2019
Figure 62. China Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Medicine for Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Medicine for Osteoarthritis Pain Sales Market Share by Countries in 2019
Figure 69. South America Medicine for Osteoarthritis Pain Revenue Market Share by Countries in 2019
Figure 70. Brazil Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Medicine for Osteoarthritis Pain Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Medicine for Osteoarthritis Pain Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Medicine for Osteoarthritis Pain Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Medicine for Osteoarthritis Pain Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Medicine for Osteoarthritis Pain Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Medicine for Osteoarthritis Pain Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Medicine for Osteoarthritis Pain Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Medicine for Osteoarthritis Pain Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Medicine for Osteoarthritis Pain Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Medicine for Osteoarthritis Pain Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Medicine for Osteoarthritis Pain Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Medicine for Osteoarthritis Pain Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
変形性関節症用鎮痛薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Osteoarthritis Pain Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Osteoarthritis …- 脊椎変形性関節症用鎮痛薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Spine Osteoarthritis Pain Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.6% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Spine Ost…
- 変形性股関節症鎮痛剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Hip Osteoarthritis Pain Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hip Osteoarthri…
- 脊椎変形性関節症用鎮痛剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Spine Osteoarthritis Pain Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Spine Osteoar…
- がん支持療法医学の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Supportive Care Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Suppor…